Prilenia Therapeutics

formerly Prilenia

A Clinical Stage Biotech Company

Amsterdam, Netherlands · Founded 2018 · $115.5M raised

Headquarters
Amsterdam
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$115.5M
Last Round
$10.0M Series BJan 2022
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 6 investors for this company. The full record is or through the API.

About

Prilenia Therapeutics B.V. is a clinical-stage biotechnology company focused on developing novel therapeutics to slow the progression of neurodegenerative diseases, including Huntington's disease and ALS. Its pipeline centers on pridopidine, which the company is advancing through clinical programs and a collaboration and license agreement with Ferrer for commercialization and co-development in Europe and other select markets. The company is led by CEO Dr. Michael Hayden, a Huntington's disease expert.

Summary

Prilenia Therapeutics is a Biotech company based in Amsterdam, Netherlands, founded in 2018. It has raised $115.5M in total across 3 rounds, most recently a $10.0M Series B round in Jan 2022. Investors include Forbion Capital Partners, Sands Capital and Sectoral Asset Management.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJan 2022
$10.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Prilenia Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/prilenia-therapeutics"><img src="https://indexed.vc/api/badge/company/prilenia-therapeutics" alt="Prilenia Therapeutics on Indexed.vc" width="260" height="76" /></a>